This notion is further supported by evidence demonstrating that β-blocker therapy in patients with dilated cardiomyopathy (DCM) can partially reverse this maladaptive transcriptional pattern by upregulating MYH6 and downregulating MYH7, an adjustment associated with improved left ventricular ejection fraction [11,12]. Here, MYH6 is linked to familial dilated cardiomyopathy.